BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 21969498)

  • 21. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
    Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
    Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer.
    Huang CW; Tsai HL; Huang MY; Huang CM; Yeh YS; Ma CJ; Wang JY
    World J Surg Oncol; 2015 Aug; 13():257. PubMed ID: 26311139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
    Lee L; Erkan A; Alhassan N; Kelly JJ; Nassif GJ; Albert MR; Rt Monson J
    Surg Oncol; 2018 Sep; 27(3):449-455. PubMed ID: 30217301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Side Really Matter? Survival Analysis among Patients with Right- Versus Left-Sided Colon Cancer: A Propensity Score-Adjusted Analysis.
    Klose J; Kloor M; Warschkow R; Antony P; Liesenfeld LF; Büchler MW; Schneider M; Tarantino I
    Ann Surg Oncol; 2021 May; 28(5):2768-2778. PubMed ID: 32959139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study.
    Hines RB; Jiban MJH; Specogna AV; Vishnubhotla P; Lee E; Zhang S
    BMC Cancer; 2019 May; 19(1):418. PubMed ID: 31053096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
    Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
    Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?
    Parsons HM; Tuttle TM; Kuntz KM; Begun JW; McGovern PM; Virnig BA
    J Am Coll Surg; 2012 Sep; 215(3):400-11. PubMed ID: 22683070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.
    Yang L; Xiong Z; Xie Q; He W; Liu S; Kong P; Jiang C; Guo G; Xia L
    BMC Cancer; 2018 May; 18(1):558. PubMed ID: 29751794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period: A SEER-Medicare Analysis.
    Jiao X; Hay JW; Sadeghi S; Barzi A
    Am J Clin Oncol; 2020 Jun; 43(6):428-434. PubMed ID: 32187027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of tumor location on long-term survival outcomes in patients with right-sided colon cancer.
    Nasseri Y; Wai C; Zhu R; Sutanto C; Kasheri E; Oka K; Cohen J; Barnajian M; Artinyan A
    Tech Coloproctol; 2022 Feb; 26(2):127-133. PubMed ID: 34993688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
    Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
    JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study.
    Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Hashiguchi Y; Sugihara K; Watanabe T
    Int J Surg; 2014; 12(9):925-30. PubMed ID: 25091400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Difference in Time to Locoregional Recurrence Between Patients With Right-Sided and Left-Sided Colon Cancers.
    Park JH; Kim MJ; Park SC; Kim MJ; Hong CW; Sohn DK; Han KS; Oh JH
    Dis Colon Rectum; 2015 Sep; 58(9):831-7. PubMed ID: 26252844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
    Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival.
    Benedix F; Kube R; Meyer F; Schmidt U; Gastinger I; Lippert H;
    Dis Colon Rectum; 2010 Jan; 53(1):57-64. PubMed ID: 20010352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study.
    Zheng C; Jiang F; Lin H; Li S
    Clin Transl Oncol; 2019 Nov; 21(11):1524-1531. PubMed ID: 30875062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
    Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
    JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics Associated With Nonreceipt of Surveillance Testing and the Relationship With Survival in Stage II and III Colon Cancer.
    Hines RB; Jiban MJH; Lee E; Odahowski CL; Wallace AS; Adams SJE; Rahman SMM; Zhang S
    Am J Epidemiol; 2021 Feb; 190(2):239-250. PubMed ID: 32902633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
    Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.
    Yahagi M; Okabayashi K; Hasegawa H; Tsuruta M; Kitagawa Y
    J Gastrointest Surg; 2016 Mar; 20(3):648-55. PubMed ID: 26573851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.